# COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy

> **NCT02465320** · PHASE2 · COMPLETED · sponsor: **Juniper Pharmaceuticals, Inc.** · enrollment: 187 (actual)

## Conditions studied

- Endometrial Biopsy

## Interventions

- **DRUG:** COL-1077
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02465320
- **Lead sponsor:** Juniper Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2016-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02465320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02465320, "COL-1077 (Lidocaine Bioadhesive Gel, 10%) in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02465320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*